Sponsor
DexCom, Inc.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name DexCom, Inc. appears in 155 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownGlobal Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose Monitoring System (Dexcom GLOW)NCT07681024 · lead sponsor · 2026-06-15
NOT_YET_RECRUITINGContinuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin Therapy in the Kingdom of Saudi ArabiaNCT07603284 · lead sponsor · 2025-11-24
ACTIVE_NOT_RECRUITINGCONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on InsulinNCT06601166 · lead sponsor · 2024-08-15
ACTIVE_NOT_RECRUITINGDexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)NCT06483945 · lead sponsor · 2024-02-28
ACTIVE_NOT_RECRUITINGEvaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 SensorNCT07681375 · lead sponsor · 2023-04-11
ACTIVE_NOT_RECRUITINGPerformance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusNCT04905628 · lead sponsor · 2021-07-08
UNKNOWNEvaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) SystemNCT04794478 · lead sponsor · 2021-02-19
COMPLETEDEvaluation of Modified Adhesives With Dexcom G6 SensorNCT04840446 · lead sponsor · 2021-02-08
COMPLETEDEvaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) SystemNCT04645641 · lead sponsor · 2020-10-12
UNKNOWNAssessing Non-adjunctive CGM Safety at Home and in New MarketsNCT04585139 · lead sponsor · 2020-10-06
COMPLETEDPrediabetes and Type 2 Diabetes Data Collection StudyNCT04503239 · lead sponsor · 2020-07-22
UNKNOWNPerformance of the Dexcom G6 Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes MellitusNCT03935191 · lead sponsor · 2019-05-01
UNKNOWNGlucose Risk Assessment in Employer PopulationsNCT04529824 · lead sponsor · 2019-04-01
COMPLETEDContinuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)NCT03620357 · lead sponsor · 2018-09-05
COMPLETEDType 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)NCT03566693 · lead sponsor · 2018-07-30
COMPLETEDContinuous Monitoring and Control of HypoglycemiaNCT03340831 · lead sponsor · 2017-10-20
UNKNOWNEvaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent SensorNCT03087877 · lead sponsor · 2017-02-03
COMPLETEDEffectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring SystemNCT02880267 · lead sponsor · 2016-05-01
COMPLETEDG5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor ApplicatorNCT02696252 · lead sponsor · 2016-01-01
COMPLETEDMultiple Daily Injections and Continuous Glucose Monitoring in DiabetesNCT02282397 · lead sponsor · 2014-09-01
COMPLETEDEffectiveness and Safety Study of the Dexcom G4 Platinum With Modified AlgorithmNCT02087995 · lead sponsor · 2013-12-01
COMPLETEDObservational Study to Evaluate the Effectiveness and Safety of the Dexcom G4 Continuous Glucose Monitoring System in PediatricsNCT02363907 · lead sponsor · 2012-09-01
COMPLETEDEffectiveness and Safety of the Dexcom™ G4 Continuous Glucose Monitoring System in Pediatric Subjects With Diabetes MellitusNCT01667185 · lead sponsor · 2012-07-01
COMPLETEDEvaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 SystemNCT01627210 · lead sponsor · 2012-05-01
COMPLETEDLong-term Use: CGM System Assessment in Adult Athletes With Diabetes MellitusNCT01627184 · lead sponsor · 2012-05-01
COMPLETEDEffectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring SystemNCT01514292 · lead sponsor · 2011-12-01
COMPLETEDObservational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring SystemNCT01514305 · lead sponsor · 2011-11-01
COMPLETEDEffectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes MellitusNCT01185496 · lead sponsor · 2010-08-01
COMPLETEDEffectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring SystemNCT01111370 · lead sponsor · 2010-02-01
COMPLETEDPivotal Study of the Intravenous Blood Glucose (IVBG) System, In-Clinic SettingNCT00925080 · lead sponsor · 2009-06-01
COMPLETEDEfficacy of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes Mellitus on Multiple Daily Injections (MDI) or Continuous Subcutaneous Insulin Infusion (CSII) TherapyNCT01104142 · lead sponsor · 2009-04-01
COMPLETEDConcurrent Use of Two Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes Mellitus (T1DM)NCT00939289 · lead sponsor · 2008-07-01
COMPLETEDEffectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring SystemNCT00722241 · lead sponsor · 2008-05-01
COMPLETEDInsulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by PredictionNCT07507708 · collaborator · 2026-05-14
RECRUITINGAcute Sauna Session and Glucose ControlNCT07520929 · collaborator · 2025-12-01
RECRUITINGThe Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin TherapyNCT06185296 · collaborator · 2025-11-15
RECRUITINGContinuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 DiabetesNCT07054125 · collaborator · 2025-08-01
RECRUITINGEarly Investigation of Glucose Monitoring After Gestational Diabetes PilotNCT06184373 · collaborator · 2025-06-06
RECRUITINGCGM for the Early Detection and Management of Hyperglycemia in PregnancyNCT06957028 · collaborator · 2025-05-27
RECRUITINGA Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 DiabetesNCT06752928 · collaborator · 2025-05-12
RECRUITINGNight Owl MetabolismNCT06507722 · collaborator · 2025-02-25
RECRUITINGEffect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)NCT06805786 · collaborator · 2025-02-11
RECRUITINGSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseNCT06217302 · collaborator · 2024-10-31
RECRUITINGSuccessfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and CoachingNCT05662462 · collaborator · 2024-07-11
RECRUITINGEarly Versus Late Monitoring Among Pregnant Women With a History of Gestational DiabetesNCT06545227 · collaborator · 2023-11-20
RECRUITINGTreating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle ModificationNCT05766735 · collaborator · 2023-08-08
RECRUITINGTelemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and DepressionNCT05734313 · collaborator · 2023-03-31
RECRUITINGUse of CGM in Kidney Transplant RecipientsNCT04783441 · collaborator · 2021-06-29
RECRUITINGRT-CGM in Young Adults at Risk of DKANCT04039763 · collaborator · 2020-09-03
RECRUITINGFrench National Cohort of People With Type 1 DiabetesNCT04657783 · collaborator · 2020-06-10
RECRUITINGContinuous Glucose Monitors (CGMs) and Readmission RatesNCT07221812 · collaborator · 2026-06-18
NOT_YET_RECRUITINGEarly Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-GenesisNCT07087340 · collaborator · 2026-01-21
COMPLETEDStelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal WellnessNCT07356986 · collaborator · 2026-01-01
NOT_YET_RECRUITINGREAL-Fam Feasibility Study for Youth Diabetes ManagementNCT07212790 · collaborator · 2025-12-15
ACTIVE_NOT_RECRUITINGA Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)NCT07039617 · collaborator · 2025-09-02
ACTIVE_NOT_RECRUITINGContinuous Glucose Monitoring (CGM) Substudy of the DECIDE RCTNCT06490874 · collaborator · 2025-09-01
WITHDRAWNAIDANET PediatricsNCT07020936 · collaborator · 2025-07-21
ACTIVE_NOT_RECRUITINGMenstrual Cycle Mapping While Using Closed-Loop Insulin DeliveryNCT07478211 · collaborator · 2025-05-09
COMPLETEDDiabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved PopulationsNCT06939413 · collaborator · 2025-03-18
ACTIVE_NOT_RECRUITINGThe YMCA Healthy Lifestyle Program for PrediabetesNCT06841796 · collaborator · 2025-02-17
ACTIVE_NOT_RECRUITINGDrugs studied in this sponsor's trials
5 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing DexCom, Inc. as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo2
exenatide1
insulin glargine1
metformin1
sotagliflozin1
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
2 trials
exenatide RxCUI 60548 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
insulin glargine RxCUI 274783 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
metformin RxCUI 6809 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
sotagliflozin RxCUI 2638675 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting
1 trial
Sponsor roles
collaborator122
lead sponsor33
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.